Back to AI Alyeska Investment Group, L.P.
NVCT1 quarters
Position history for AIAlyeska Investment Group, L.P.'s holdings in NUVECTIS PHARMA INC
Alyeska Investment Group, L.P. holds 275,000 shares of NVCT (NUVECTIS PHARMA INC), worth $5.1M as of 2026-Q2. This is a new position. NVCT represents 0.0% of Alyeska Investment Group, L.P.'s portfolio.
Current Value
$5.1M
Current Shares
275,000
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC